| Catalog Number | CBCL-406 |
| Price | Online Inquiry |
| Unit Quantity | 1x106 cells / 1.0 ml |
Stable HepG2 clone expressing exogenous human PDL1 gene
Drug screening and biological assays
PD-L1, also called human programmed cell death ligand 1, is a transmembrane protein that plays a significant role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease, virus infection, and cancer. PD-L1 binds to its receptor PD-1 on activated T cells, B cells, and myeloid cells to modulate activation or inhibition. Upregulation of PD-L1 can allow the cancer cell to evade the host immune system.
| Category | Immune Molecules Cell Lines |
| Cell Line Name | Human PDL1 Stable HepG2 Cell Line |
| Pharmaceutical Target | Immune Molecules |
| Species | Human |
| Host Cell Line | HepG2 |
| Cell Type | Human Liver Cancer Cell Line |
| Morphology | Epithelial |
| Growth Properties | Adherent |
| Selection Marker | Puromycin and hygromycin B |
| Seeding Density | Thaw entire contents into an appropriate T25 flask. |
| Subculture Ratio | Recommended a ratio of 1:10. |
| Doubling Time | Approximately 40 hours |
| Recommended Medium | RPMI1640 + 10% FBS+ 1 μg/ml Puromycin |
| Storage Method | Frozen in liquid nitrogen with 70% medium, 20% FBS and 10% DMSO |
| Stability | Stable in culture over 10 passages |
| QC | WB |
| Shipping | Shipping in dry ice |
| Biosafety Level | BSL-1 |
| Caution | For Research Use Only |